Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: Primary influenza pneumonia versus concomitant/secondary bacterial pneumonia

Influenza and other Respiratory Viruses

Volumn 5, Issue 6, 2011, Pages

  Song, Joon Y ^a   Cheong, Hee J ^a   Heo, Jung Y ^a   Noh, Ji Y ^a   Yong, Hwan S ^a   Kim, Yoon K ^a   Kang, Eun Y ^a   Choi, Won S ^a   Jo, Yu M ^a   Kim, Woo J ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

2009 H1N1; C reactive protein; Influenza; Pneumonia; Procalcitonin

Indexed keywords

AMANTADINE; AZITHROMYCIN; C REACTIVE PROTEIN; CEFTRIAXONE; LACTATE DEHYDROGENASE; LEVOFLOXACIN; OSELTAMIVIR; PROCALCITONIN; RIBAVIRIN; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; FATALITY; FEMALE; HEADACHE; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H1N1) PNEUMONIA; INFLUENZA VIRUS A H1N1; KOREA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYALGIA; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; KOREA; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 80054781727     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2011.00269.x     Document Type: Article

References (35)

1. Prevention KCfDCa. Korean Influenza Surveillance Report, 2008-2009. 2009.
2. Jia N, de Vlas SJ, Liu YX et al. Serological reports of human infections of H7 and H9 avian influenza viruses in northern China. J Clin Virol 2009; 44:225-229.
3. Organization WH. Recommendations and laboratory procedures for detection of avian influenza A(H5N1) virus in specimens from suspected human cases. 2007.
4. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2):S27-S72.
5. Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004; 103:133-138.
6. Kendal AP, Pereira MS, Skehel JJ. Concepts and Procedures for Laboratory Based Influenza Surveillance. Geneva: Viral Disease Unit, World Health Organization, 1982.
7. Nicholson KG. Textbook of Influenza; in: Nicholson KG, Webster RG, Hay AJ (eds): Human Influenza. London: Blackwell Science Ltd, 1998; 219-264.
8. Childs RA, Palma AS, Wharton S et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 2009; 27:797-799.
9. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440:435-436.
10. Shinya K, Kawaoka Y. [Influenza virus receptors in the human airway]. Uirusu 2006; 56:85-89.
11. van den Brand JM, Stittelaar KJ, van Amerongen G et al. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis 2010; 201:993-999.
12. Blyth CC, Iredell JR, Dwyer DE. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 361:2493.
13. Singh K, Vasoo S, Stevens J, Schreckenberger P, Trenholme G. Pitfalls in the diagnosis of pandemic (Novel) A/H1N1 2009 influenza. J Clin Microbiol 2010; 48:1501-1503.
14. Fraser C, Donnelly CA, Cauchemez S et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324:1557-1561.
15. Oliveira W, Carmo E, Penna G et al. Pandemic H1N1 influenza in Brazil: analysis of the first 34, 506 notified cases of influenza-like illness with severe acute respiratory infection (SARI). Euro Surveill 2009; 14:1-6.
16. Donaldson LJ, Rutter PD, Ellis BM et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009; 339:b5213.
17. Kamigaki T, Oshitani H. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr 2009; 1:RRN1139.
18. Presanis AM, De AngelisD, Hagy A et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009; 6:e1000207.
19. Chan MC, Chan RW, Yu WC et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 2010; 176:1828-1840.
20. Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, Yuen KY. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis 2010; 201:346-353.
21. Beigel JH, Farrar J, Han AM et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374-1385.
22. Cheung CY, Poon LL, Lau AS et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360:1831-1837.
23. Coleman JR. The PB1-F2 protein of influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J 2007; 4:9.
24. McAuley JL, Zhang K, McCullers JA. The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 2010; 84:558-564.
25. Agarwal PP, Cinti S, Kazerooni EA. Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. AJR Am J Roentgenol 2009; 193:1488-1493.
26. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680-689.
27. Diez-Padrisa N, Bassat Q, Machevo S et al. Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area. PLoS ONE 2010; 5:e13226.
28. Lai CC, Tan CK, Chen SY et al. Diagnostic performance of procalcitonin for bacteremia in patients with bacterial infection at the emergency department. J Infect 2010; 61:512-515.
29. Ingram PR, Inglis T, Moxon D, Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 2010; 36:528-532.
30. Given K, Schultz A, Douglas TA, Martin AC. Air leaks in children with acute bronchiolitis. J Paediatr Child Health 2008; 44:604-606.
31. Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-1944.
32. Prevention CfDCa. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009; 58:749-752.
33. Cunha BA. Swine Influenza (H1N1) pneumonia: clinical considerations. Infect Dis Clin North Am 2010; 24:203-228.
34. Smee DF, Hurst BL, Wong MH, Bailey KW, Morrey JD. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob Agents Chemother 2009; 53:2120-2128.
35. Babcock HM, Merz LR, Dubberke ER, Fraser VJ. Case-control study of clinical features of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:921-926.